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CORRESPONDENCE 
Expectant management of twin pregnancy 
with single fetal death 
Sir, 
We wish to comment on the antenatal monitoring of the 
surviving co-twins in the study of Santema et al. (Vol 102, 
January 1995). In their study fetal condition was assessed serially 
with ultrasound scan and cardiotocogram (CTG) and no 
neurological morbidity was recorded. 
Despite this result, it is important to recognise the limitation of 
these antenatal surveillance tests. Biophysical profile and CTG 
monitor biophysical events regulated by the brainstem, and this 
part of the brain may be spared during neurological insult. 
In one of the cases reported by D’Alton et al. (1984) severe 
neurological damage occurred in the surviving co-twin, despite 
normal ultrasound and reactive antenatal CTG. Postnatal 
computerised tomographic scan revealed an intact brainstem. 
J. 0. Arayomi & E. D. Pereira 
Department of‘ Obstetrics and Gynaecology, Pilgrim Hospital, 
Boston, South Lincolnsltire PE2I 9QS 
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We are grateful for the interest showing in our study by Drs 
Arayomi and Pereira. We agree that a reactive cardiotocogram 
does not exclude major fetal cerebral damage in the presence of 
an intact brainstem. At present we have no accurate method to 
diagnose the development or existence of such fetal neurological 
damage. Because our data suggest that it may be a relatively rare 
event, we feel that it does not constitute an argument against 
expectant management of twin pregnancy with single fetal death 
unless the fetal cardiotocogram is suggestive of fetal compromise. 
J. G. Santema & H. C. S. Wallenburg 
Department of obstetrics and Gynaecology, Erasmus Universitv 
School of Medicine and Health Sciences, 3000 DR Rotterdam, The 
Netherland? 
Local research ethics committees: hindrance 
or help? 
Sir, 
We sympathise with the frustrations of Penn and Steer (Vol 102, 
January 1995) in their attempts to obtain approval from various 
local ethics committees for a multi-centre trial, and we share their 
disappointment that the preterm breech trial failed. As consumer 
representatives. we are in favour of well-designed randomised 
trials, and we have lost an important study. 
Inefficiency and ignorance of the kind they describe are 
inexcusable. However, they do not make out a case for the drastic 
proposal to bypass local committees, leaving them only with the 
power of veto. Proposals are rarely turned down, but they are 
often usefully amended and improved by comrqittee members, 
whose knowledge and experience is increasing now that training 
is available. 
The fact that two committees insisted on longer term follow up 
of babies involved in the study shows that changes suggested were 
far from trivial or unimportant. The AIMS policy for research on 
pregnancy, childbirth and the newborn requires keeping names of 
research subjects so that long term follow up is possible (Robinson 
1994). It would be helpful if Penn and Steer were to share with us 
information on other changes requested, so that we may judge 
their ethical value. 
A national committee is not necessarily the fount of all 
wisdom. One of us (J. R.) while sitting on the GMC Professional 
Conduct Committee, was concerned about ethical problems 
revealed in a trial approved by one national committee, and as a 
result the President wrote to the body concerned. AIMS’ criticisms 
of a multi-centre trial show that serious ethical problems can be 
missed if there is inadequate consultation (Robinson 1994). 
Wider consideration can be valuable protection for researchers, 
since it reduces the likelihood of ethical criticisms after 
publication. There are also often local factors (e.g., ethnicity, 
culture, availability of staff) affecting research which the district 
committee will be aware of but the national committee will not. 
Hindrances from local ethics committees can be reduced or 
avoided. There might even be a case for prioritising multi-centre 
trial applications, but the help and valuable experience which 
many local committees offer should be thrown aside. 
Beverley A. Lawrence Beech & Jean Robinson 
Association for Improvements in the Maternity Services, 21 Iver 
Lane, Iver. Buckinghamshire SU, 9LH 
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Interleukin-6, tumour necrosis factor and 
soluble tumour necrosis factor receptors in 
women with pre-eclampsia 
Sir, 
We were interested to read this paper by Vince et a/. (Vol 102, 
January 1995) because their conclusions were similar to those we 
drew from an investigation of tumour necrosis factor-alpha 
(TNF-a) and soluble E-selectin in pre-eclampsia (Meekins et al. 
1994). E-selectin was studied because it is expressed by 
endothelium in response to TNF-a and interleukin-I (IL-I); like 
interleukin-6, it is an indirect measurement of the activity of these 
cytokines. 
Maternal blood samples were collected from singleton preg- 
nancies at different gestational ages: TNF-a and soluble E- 
selectin were measured by sandwich ELISA techniques. The 
women studied included 10 normal pregnancies who later 
developed pre-eclampsia, nine with established PET. and 22 
controls whose pregnancies were clinically normal throughout 
and whose babies were of normal birthweight. Pre-eclampsia was 
defined according to the criteria of Davey and MacGillivray 
(1988) as a diastolic blood pressure greater than 90 mmHg on 
two or more consecutive occasions more than 4 h apart and with 
more than 300 mg of protein in a 24 h urine collection. or 2 + 
proteinuria detected on reagent strip on two occasions more than 
4 h apart. 
In the 10 women who later developed pre-eclampsia. TNF-a 
was below the immunoassay limit of detection (<  80 pg/ml) onc 
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